Name: | bromodiphenhydramine |
---|---|
PubChem Compound ID: | 15736 |
Molecular formula: | C17H21BrClNO |
Molecular weight: | 370.711 g/mol |
Synonyms: |
1808-12-4; 2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochoride; Bromazine hydrochloride; EINECS 217-310-9; Ambodryl; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride; Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride (9CI); ETHYLAMINE, 2-((p-BROMO-alpha-PHENYLBENZYL)OXY)-N,N-DIMETHYL-, HYDROCHLORIDE; 2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine hydrochloride.
show more » |
Name: | bromodiphenhydramine |
---|---|
Name (isomeric): | DB01237 |
Drug Type: | small molecule |
Synonyms: |
Bromazine hydrochloride; Amodryl; Bromdiphenhydramine; Bromazine; Bromazin; Bromanautine; Bromdiphenhydramine hydrochloride; Bromodiphenhydramine hydrochloride; Ambodryl Hydrochloride; Bromdiphenylhydramine Hydrochloride
|
Brand: | Bromo-Benzdryl, Histabromamine, Deserol, Neo-Benadryl, Bromo-Benadryl |
Brand name mixture: | Ambenyl Cough Syrup(Ammonium Chloride + Bromodiphenhydramine Hydrochloride + Codeine Phosphate + Diphenhydramine Hydrochloride + Potassium Guaiacol Sulphonate) |
Category: | Antihistamines |
CAS number: | 1808-12-4 |
Indication: | For management of symptoms related to hay fever and other types of allergy and used to help bring up phlegm, thin secretions, and make a cough productive. |
---|---|
Pharmacology: |
Bromodiphenhydramine is an antihistamine of the ethanolamine class. Ethanolamine antihistamines have significant antimuscarinic activity and produce marked sedation in most patients. In addition to the usual allergic symptoms, the drug also treats irritant cough and nausea, vomiting, and vertigo associated with motion sickness. It also is used comm...
show more » |
Mechanism of Action: | Bromodiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. |
Absorption: | Well absorbed in the digestive tract. |
Protein binding: | 96% |
Biotransformation: | Hepatic (cytochrome P-450 system); some renal. |
Half Life: | 1 to 4 hours |
Toxicity: | Signs of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, swelling of face, lips, tongue, or throat. |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|